150 related articles for article (PubMed ID: 21880642)
1. High pentraxin 3 level predicts septic shock and bacteremia at the onset of febrile neutropenia after intensive chemotherapy of hematologic patients.
Vänskä M; Koivula I; Hämäläinen S; Pulkki K; Nousiainen T; Jantunen E; Juutilainen A
Haematologica; 2011 Sep; 96(9):1385-9. PubMed ID: 21880642
[TBL] [Abstract][Full Text] [Related]
2. Asymmetric dimethylarginine in the assessment of febrile neutropenia in hematological patients.
Lappalainen M; Hämäläinen S; Juutilainen A; Koivula I; Pulkki K; Jantunen E
Scand J Clin Lab Invest; 2017 Apr; 77(2):130-134. PubMed ID: 28218011
[TBL] [Abstract][Full Text] [Related]
3. Plasma copeptin in the assessment of febrile neutropenia.
Purhonen AK; Vänskä M; Hämäläinen S; Pulkki K; Lehtikangas M; Kuittinen T; Nousiainen T; Koivula I; Jantunen E; Juutilainen A
Peptides; 2012 Jul; 36(1):129-32. PubMed ID: 22580173
[TBL] [Abstract][Full Text] [Related]
4. IL-10 combined with procalcitonin improves early prediction of complications of febrile neutropenia in hematological patients.
Vänskä M; Koivula I; Jantunen E; Hämäläinen S; Purhonen AK; Pulkki K; Juutilainen A
Cytokine; 2012 Dec; 60(3):787-92. PubMed ID: 22902948
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with severe sepsis: prospective study of 94 neutropenic febrile episodes.
Jeddi R; Achour M; Amor RB; Aissaoui L; Bouterâa W; Kacem K; Lakhal RB; Abid HB; BelHadjAli Z; Turki A; Meddeb B
Hematology; 2010 Feb; 15(1):28-32. PubMed ID: 20132659
[TBL] [Abstract][Full Text] [Related]
6. Pentraxin 3 predicts complicated course of febrile neutropenia in haematological patients, but the decision level depends on the underlying malignancy.
Juutilainen A; Vänskä M; Pulkki K; Hämäläinen S; Nousiainen T; Jantunen E; Koivula I
Eur J Haematol; 2011 Nov; 87(5):441-7. PubMed ID: 21676033
[TBL] [Abstract][Full Text] [Related]
7. Predictive factors of septic shock and mortality in neutropenic patients.
Ramzi J; Mohamed Z; Yosr B; Karima K; Raihane B; Lamia A; Hela BA; Zaher B; Balkis M
Hematology; 2007 Dec; 12(6):543-8. PubMed ID: 17852435
[TBL] [Abstract][Full Text] [Related]
8. Soluble CD14 as a Diagnostic and Prognostic Biomarker in Hematological Patients with Febrile Neutropenia.
Korpelainen S; Intke C; Hämäläinen S; Jantunen E; Juutilainen A; Pulkki K
Dis Markers; 2017; 2017():9805609. PubMed ID: 28845081
[TBL] [Abstract][Full Text] [Related]
9. Source of Circulating Pentraxin 3 in Septic Shock Patients.
Albert Vega C; Mommert M; Boccard M; Rimmelé T; Venet F; Pachot A; Leray V; Monneret G; Delwarde B; Brengel-Pesce K; Mallet F; Trouillet-Assant S
Front Immunol; 2018; 9():3048. PubMed ID: 30687307
[TBL] [Abstract][Full Text] [Related]
10. Imbalances in serum angiopoietin concentrations are early predictors of septic shock development in patients with post chemotherapy febrile neutropenia.
Alves BE; Montalvao SA; Aranha FJ; Siegl TF; Souza CA; Lorand-Metze I; Annichino-Bizzacchi JM; De Paula EV
BMC Infect Dis; 2010 May; 10():143. PubMed ID: 20509945
[TBL] [Abstract][Full Text] [Related]
11. Risk index score for bacteremia in febrile neutropenic episodes in children with malignancies.
Spasova MI; Grudeva-Popova JG; Kostyanev SS; Genev ED; Stoyanova AA; Kirina VI; Moumdjiev IN
J BUON; 2009; 14(3):411-8. PubMed ID: 19810131
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of protein C concentrations in neutropenic patients at high risk of severe septic complications.
Mesters RM; Helterbrand J; Utterback BG; Yan B; Chao YB; Fernandez JA; Griffin JH; Hartman DL
Crit Care Med; 2000 Jul; 28(7):2209-16. PubMed ID: 10921542
[TBL] [Abstract][Full Text] [Related]
13. Serum procalcitonin as an independent diagnostic markers of bacteremia in febrile patients with hematologic malignancies.
Yang M; Choi SJ; Lee J; Lee DG; Kim YJ; Park YJ; Oh EJ
PLoS One; 2019; 14(12):e0225765. PubMed ID: 31821331
[TBL] [Abstract][Full Text] [Related]
14. Pentraxin 3 and C-reactive protein in severe meningococcal disease.
Sprong T; Peri G; Neeleman C; Mantovani A; Signorini S; van der Meer JW; van Deuren M
Shock; 2009 Jan; 31(1):28-32. PubMed ID: 18650775
[TBL] [Abstract][Full Text] [Related]
15. Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein.
von Lilienfeld-Toal M; Dietrich MP; Glasmacher A; Lehmann L; Breig P; Hahn C; Schmidt-Wolf IG; Marklein G; Schroeder S; Stuber F
Eur J Clin Microbiol Infect Dis; 2004 Jul; 23(7):539-44. PubMed ID: 15221617
[TBL] [Abstract][Full Text] [Related]
16. Lipopolysaccharide-binding protein: a possible diagnostic marker for Gram-negative bacteremia in neutropenic cancer patients.
Oude Nijhuis CSM; Vellenga E; Daenen SMGJ; van der Graaf WTA; Gietema JA; Groen HJM; Kamps WA; de Bont ESJM
Intensive Care Med; 2003 Dec; 29(12):2157-2161. PubMed ID: 14569424
[TBL] [Abstract][Full Text] [Related]
17. Pentraxin-3 Predicts Short- and Mid-term Mortality in Patients with Sepsis and Septic Shock During Intensive Care Treatment.
Hamed S; Behnes M; Pauly D; Lepiorz D; Barre M; Becher T; Lang S; Akin I; Borggrefe M; Bertsch T; Hoffmann U
Clin Lab; 2018 Jun; 64(6):999-1011. PubMed ID: 29945330
[TBL] [Abstract][Full Text] [Related]
18. Viridans streptococcal bacteremia and viridans streptococcal shock syndrome in neutropenic patients: comparison between children and adults receiving chemotherapy or undergoing bone marrow transplantation.
Martino R; Subirá M; Manteiga R; Badell I; Argilés B; Sureda A; Brunet S
Clin Infect Dis; 1995 Feb; 20(2):476-7. PubMed ID: 7742466
[No Abstract] [Full Text] [Related]
19. Pentraxin 3, a Predicator for 28-Day Mortality in Patients With Septic Shock.
Jie H; Li Y; Pu X; Ye J
Am J Med Sci; 2017 Mar; 353(3):242-246. PubMed ID: 28262210
[TBL] [Abstract][Full Text] [Related]
20. Persisting high levels of plasma pentraxin 3 over the first days after severe sepsis and septic shock onset are associated with mortality.
Mauri T; Bellani G; Patroniti N; Coppadoro A; Peri G; Cuccovillo I; Cugno M; Iapichino G; Gattinoni L; Pesenti A; Mantovani A
Intensive Care Med; 2010 Apr; 36(4):621-9. PubMed ID: 20119647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
